Paragon Private Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Paragon Private Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83M	Sell	13,916 -1,452	-9%	-$273K	0.74%	33
2026 Q1	$2.89M	Buy	15,368 +775	+5%	+$149K	0.9%	22
2025 Q4	$2.76M	Buy	14,593 +1,199	+9%	+$222K	0.85%	23
2025 Q3	$2.22M	Buy	13,394 +9,254	+224%	+$1.51M	0.73%	33
2025 Q2	$635K	Buy	+4,140	New	+$617K	0.25%	111

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Paragon Private Wealth Management's BBH Position: Q2 2026 in Review

Paragon Private Wealth Management reduced its VanEck Biotech ETF (BBH) stake by 9.4% in Q2 2026, selling an estimated $273K and leaving 13,916 shares worth $2.83M. The position accounts for 0.74% of the portfolio, ranked #33.

Paragon Private Wealth Management first reported a position in BBH in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.89M in Q1 2026. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Paragon Private Wealth Management held 13,916 shares of VanEck Biotech ETF worth $2.83M as of Q2 2026.
Paragon Private Wealth Management sold 1,452 VanEck Biotech ETF shares in Q2 2026, an estimated $273K.
VanEck Biotech ETF made up 0.74% of Paragon Private Wealth Management's portfolio in Q2 2026, its #33 holding.
Paragon Private Wealth Management first reported a position in VanEck Biotech ETF in Q2 2025 and has held it in 5 quarters since.
Paragon Private Wealth Management's VanEck Biotech ETF position peaked at $2.89M in Q1 2026.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.